Stem Cell Transplantation in Crohn's Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Crohn Disease
Interventions
DRUG

Mesna

"Stem Cell Mobilization: Infused according to institutional guidelines;~Post-PBSC Infusion Conditioning: Mesna provided with Cytoxan according to institutional protocol."

DRUG

Cyclophosphamide

"Stem Cell Mobilization:~Cyclophosphamide (CY) infused intravenously over 1 hour: 50 mg/kg (25 mg/kg/day on 2 consecutive days)"

DRUG

Filgrastim

"Stem Cell Mobilization: Filgrastim (G-CSF) 10 mcg/kg SC will start 5 days after the last dose of CY and will end the day before the last leukapheresis;~Post-PBSC Infusion Conditioning: Filgrastim administered intravenously 5 mcg/kg IV starting day + 5, continue until ANC of \>1000/μL"

PROCEDURE

Apheresis catheter placement

Subjects will require placement of an Apheresis catheter by Intervention Radiologists on the day of collection of stem cells.

PROCEDURE

Leukapheresis

Leukapheresis will be performed on a continuous flow separator machine according to institutional guidelines to target 3-8 x 10\^6 CD34+ cells/kg body weight.

DRUG

Fludarabine

Preparative/Conditioning Regime Fludarabine given as 30 mg/m2 per dose x 4 days, beginning on day -6.

DRUG

Methylprednisolone

Preparative/Conditioning Regime r-ATG pre-medication according to institutional guidelines

DRUG

Diphenhydramine

Preparative/Conditioning Regime r-ATG premedication according to institutional guidelines

DRUG

Acetaminophen

Preparative/Conditioning Regime r-ATG premedication according to institutional guidlines

DRUG

anti-thymocyte globulin (rabbit)

Preparative/Conditioning Regime r-ATG administered intravenously: 2.5 mg/kg/dose IV over 6 hours on specified days (day -6,-4,-2); ); total 3 doses=7.5 mg/kg.

DRUG

lymphocyte immune globulin

Preparative/Conditioning Regime In patients who develop severe allergic reactions to rATG (Thymoglobulin), it may be substituted by horse ATG (hATG, ATGAM, Pharmacia \& Upjohn, Kalamazoo, MI). The recommended dose of hATG is 25 mg/kg/day for 3 doses.

BIOLOGICAL

Peripheral Blood Stem Cell Infusion

PBSC (peripheral blood stem cell) infusion on day 0 as per institutional guidelines.

DRUG

Cytoxan

Post-PBSC Infusion Conditioning Cytoxan infused intravenously: 50mg/kg/day x 2 days. Infused over 2 hours with adequate hydration or according to institutional guidelines.

Trial Locations (1)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER